Acadian Asset Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Sell
39,755
-87,513
-69% -$359K ﹤0.01% 1660
2025
Q4
$468K Buy
127,268
+27,305
+27% +$234K ﹤0.01% 1322
2025
Q3
$1.41M Buy
99,963
+75,622
+311% +$1.18M ﹤0.01% 972
2025
Q2
$464K Sell
24,341
-64,958
-73% -$1.01M ﹤0.01% 1155
2025
Q1
$985K Buy
89,299
+22,200
+33% +$265K ﹤0.01% 940
2024
Q4
$1.11M Sell
67,099
-19,776
-23% -$247K ﹤0.01% 907
2024
Q3
$881K Buy
86,875
+32,237
+59% +$959K ﹤0.01% 947
2024
Q2
$3.15M Buy
54,638
+2,689
+5% +$132K 0.01% 633
2024
Q1
$1.73M Buy
51,949
+40,881
+369% +$2.07M 0.01% 694
2023
Q4
$896K Buy
+11,068
New +$901K ﹤0.01% 892

Other funds holding OM

Acadian Asset Management's OM Position: Q1 2026 in Review

Acadian Asset Management reduced its Outset Medical (OM) stake by 69% in Q1 2026, selling an estimated $359K and leaving 39,755 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

Acadian Asset Management first reported a position in OM in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.15M in Q2 2024. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Acadian Asset Management held 39,755 shares of Outset Medical worth $149K as of Q1 2026.
  • Acadian Asset Management sold 87,513 Outset Medical shares in Q1 2026, an estimated $359K.
  • Outset Medical made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1660 holding.
  • Acadian Asset Management first reported a position in Outset Medical in Q4 2023 and has held it in 10 quarters since.
  • Acadian Asset Management's Outset Medical position peaked at $3.15M in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.